Background: The detection of fabrication or error within the scientific literature is an 8 important and underappreciated problem. Retraction of scientific articles is rare, but 9 retraction may also be conservative, leaving open the possiblity that many fabricated or 10 erroneous findings remain in the literature as a result of lack of scrutiny. A recently statistical 11 analysis of randomized controlled trials [1] has suggested that the reported statistics form 12 these trials deviate substantially from expectation under truely random assignment, raising 13 the possiblity of fraud or error. It has also been proposed that the method used could be 14 implemented to prospectively screen research, for example by applying the method prior to 15 publication.
Results
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To facilate understanding of the theoretical and empirical results I present, I briefly review 124 the method utilized by Carlisle (which I refer to as the CM) [1] . For a single randomized 125 controlled trial, the CM first involves manually extracting summary statistics on baseline 126 (pre-treatment) variables from all groups which are randomized. For each variable, a p-value is 127 calculated which tests the null hypothesis that the population means of the variable are equal 128 across the groups. If the groups were truely assigned at random, then the null hypothesis 129 is expected to be true for all of the variables. To combine the tests for all variables, the 130 CM as applied in [1] utilized several methods for combining p-values that test a common 131 null hypothesis, but [1] focuses on Stouffer's method [23] , which transforms the p-values 132 to z-scores and calculates their sum. Under the assumption that the p-values included are 133 independent, this sum is then compared to its own null distribution to derive a global p-value. 134 Below, I highlight several stages at which this process may go wrong, along with re-analyses 135 of the data used in [1] showing that these issues plausibly effected the analysis. 137 The CM as implemented in [1] involves calcuating p-values for for the differences in means of 138 individual baseline variables within each trial using summary statistics, and then aggregating 139 the p-values across each trial. Issues in the calcuation of the p-value for each variable may 140 impact the validity of the downstream analysis. In order to test the ability of the method 141 used by Carlisle [1] to recalculate p-values from summary statistics, I simulate data from 142 two identically distributed groups and apply two of the p-value calculation methods used by 143 Carlisle, a Monte Carlo method and ANOVA. The null hypothesis is true in these simulations, data from log-normal distributions instead of normal, as assumed in Carlisle's analysis [1, 13] . 149 Second, I include rounding of reported summary statistics. and one of these factors is application to the study, the CM may produce produce an extreme 187 8 p-value for that study as a result of one of these factors rather than as a result of data 188 validity issues. Likewise, for the global assessment of the prevalence of data validity issues 189 in randomized control trials, deviations like those observed in [1] may be the result of a 190 combination of these factors rather than a high prevalence of data validity issues. for the first variable in each trial (D).
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Calculation of variable-level p-values from summary statistics
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One objection to this is that the similarity between Fig 3B and In general, it is difficult to definitively identify the cause of the deviation from uniformity across several retraction categories (Fig 4A and E) . indicative of error, suggesting that this critique is not simply speculation.
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Implications for use of the CM for screening 315 The theoretical arguments I give also have implications for the use of the CM in screening.
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In p-values compared to other fabrication-related retractions (Fig 4A and E) . This suggests
